Thomas Villiger
Chief Executive Officer at Mepha AG
Profile
Thomas Villiger is currently the Chief Executive Officer at Mepha AG, Director at REOFIN Invest AG, Director at Sigvaris Holding AG, and President at Haiku Foundation.
Previously, he was the Vice Chairman at Siegfried Holding AG from 2015 to 2017 and a Director at Dolder AG.
He received a doctorate degree from the Swiss Federal Institute of Technology in 1979.
Thomas Villiger active positions
Companies | Position | Start |
---|---|---|
Mepha AG
Mepha AG Pharmaceuticals: MajorHealth Technology Mepha develops and makes interesting pharmaceuticals in Switzerland, as well as offering attractive services, so that doctors and pharmacists can treat their patients both more effectively and in a more price-conscious way. This is achieved by team work and innovative spirit, examples of which are as follows. Its innovative dosage forms are more readily accepted by patients, so the patient compliance is higher, which makes for a more effective treatment. It has been involved in the fight against malaria for over 20 years, and introduced a state-of-the-art combination drug with the active substances mefloquine and artesunate (Artequin™) on the international market in 2002 for the treatment of this disease. It can offer many creative services and target-oriented two-way communication to help its clients in the treatment of their patients. Its highly motivated employees add their friendly approach to its comprehensive portfolio for the benefit of its clients. | Chief Executive Officer | 2010-02-07 |
REOFIN Invest AG | Director/Board Member | - |
Sigvaris Holding AG
Sigvaris Holding AG Medical SpecialtiesHealth Technology Sigvaris Holding AG manufactures medical compression stockings. Its products include medical, well being, and sports. The firm's medical line helps in the treatment of venous disorder. The company was founded in 1864 and is headquartered in Appenzell, Switzerland. | Director/Board Member | - |
Haiku Foundation | President | - |
Former positions of Thomas Villiger
Companies | Position | End |
---|---|---|
SIEGFRIED HOLDING AG | Director/Board Member | 2017-04-19 |
Dolder AG
Dolder AG Wholesale DistributorsDistribution Services Part of Dolder Bigler AG, Dolder AG is a Swiss company that specializes in producing high-quality plastics and specialty chemicals. The private company is based in Basel, Switzerland and works with other industry leaders such as Coim, Eastman, Evonik, and Huntsman to provide top-of-the-line products for their customers. The company's laripur® tpu and ™ copolyester products are used for injection molding and extrusion, and offer a soft touch effect and higher heat and chemical resistance than other materials. | Director/Board Member | - |
Training of Thomas Villiger
Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SIEGFRIED HOLDING AG | Health Technology |
Private companies | 5 |
---|---|
Dolder AG
Dolder AG Wholesale DistributorsDistribution Services Part of Dolder Bigler AG, Dolder AG is a Swiss company that specializes in producing high-quality plastics and specialty chemicals. The private company is based in Basel, Switzerland and works with other industry leaders such as Coim, Eastman, Evonik, and Huntsman to provide top-of-the-line products for their customers. The company's laripur® tpu and ™ copolyester products are used for injection molding and extrusion, and offer a soft touch effect and higher heat and chemical resistance than other materials. | Distribution Services |
Mepha AG
Mepha AG Pharmaceuticals: MajorHealth Technology Mepha develops and makes interesting pharmaceuticals in Switzerland, as well as offering attractive services, so that doctors and pharmacists can treat their patients both more effectively and in a more price-conscious way. This is achieved by team work and innovative spirit, examples of which are as follows. Its innovative dosage forms are more readily accepted by patients, so the patient compliance is higher, which makes for a more effective treatment. It has been involved in the fight against malaria for over 20 years, and introduced a state-of-the-art combination drug with the active substances mefloquine and artesunate (Artequin™) on the international market in 2002 for the treatment of this disease. It can offer many creative services and target-oriented two-way communication to help its clients in the treatment of their patients. Its highly motivated employees add their friendly approach to its comprehensive portfolio for the benefit of its clients. | Health Technology |
Sigvaris Holding AG
Sigvaris Holding AG Medical SpecialtiesHealth Technology Sigvaris Holding AG manufactures medical compression stockings. Its products include medical, well being, and sports. The firm's medical line helps in the treatment of venous disorder. The company was founded in 1864 and is headquartered in Appenzell, Switzerland. | Health Technology |
Haiku Foundation | |
REOFIN Invest AG |
- Stock Market
- Insiders
- Thomas Villiger